Is Nucleic Acids Research Indexed in PubMed? Yes, With Active MEDLINE and PMC
Nucleic Acids Research is indexed in PubMed and currently indexed for MEDLINE, with searchable coverage from volume 1, issue 1 in January 1974 and PMC support.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Nucleic Acids Research at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 13.1 puts Nucleic Acids Research in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~~45% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: Nucleic Acids Research takes ~45 days median. A faster-turnaround journal may suit a grant or job deadline better.
- If open access is required by your funder, verify the journal's OA agreements before submitting.
Quick answer: yes. Nucleic Acids Research is indexed in PubMed, currently indexed for MEDLINE, and also listed in PubMed Central. The journal has searchable coverage from volume 1, issue 1 in January 1974.
That matters because NAR papers often function as long-lived methods, database, and resource references. PubMed plus PMC helps those papers stay discoverable and reusable well after publication.
Direct answer
If you publish in Nucleic Acids Research, the article is discoverable in PubMed and the journal remains actively indexed for MEDLINE.
NLM field | What the record shows | Why it matters |
|---|---|---|
publication start year | 1974 | the title has long-running continuity |
PubMed coverage | v1n1, Jan. 1974- | searchable coverage starts from the first issue |
MEDLINE coverage | v1n1, Jan. 1974- | the journal sits inside the curated NLM journal index |
PMC | listed in PMC | there is also a full-text archive route |
current indexing status | Currently indexed for MEDLINE | this is active indexing, not archive residue |
current subset | Index Medicus | the title sits inside the standard biomedical indexing structure |
That is the practical answer. The journal is visible in PubMed, active in MEDLINE, and supported by PMC for full-text discoverability.
Why this matters for Nucleic Acids Research
The strongest NAR papers often need to reach:
- molecular biologists
- genomics and transcriptomics readers
- database and resource users
- assay and methods adopters
- computational groups scanning for a reusable reference
Those readers usually search by molecule, method, workflow, database, or biological question rather than by browsing the latest issue. PubMed indexing matters because it helps the paper show up inside that real discovery workflow.
For NAR, PMC matters too. Database papers, methods papers, and resource descriptions often keep paying back when readers can reopen the full text directly, not just find the abstract.
What the indexing record tells you in practice
Practical question | What the record tells you |
|---|---|
will a published NAR paper surface in standard biomedical search? | yes |
is the title actively indexed for MEDLINE? | yes |
is there also a PMC route for full-text visibility? | yes |
does searchable coverage begin from the first issue? | yes |
does indexing prove the work is the right fit for NAR? | no |
That last distinction matters because the database answer is easier than the editorial-fit answer.
PubMed, MEDLINE, and PMC for Nucleic Acids Research
- PubMed means the article is visible in the main biomedical search interface.
- MEDLINE means the journal remains part of the curated NLM journal index.
- PMC means there is also a PubMed Central route for full-text access.
- Index Medicus indicates the title sits inside the standard biomedical indexing structure.
For this journal, all three signals matter. Many NAR papers are not one-time reads. They are reused as reference points for methods, databases, protocols, and field infrastructure.
How this compares with nearby journals
Journal pattern | What the indexing record usually supports | What it does not solve |
|---|---|---|
Nucleic Acids Research | strong discoverability for methods, databases, and molecular biology resources | whether the work has the right resource or methods identity |
narrower genomics or bioinformatics journals | strong visibility within one lane | broader molecular-biology reach |
primary-research flagships | broad biomedical visibility | whether a resource or database paper fits those editorial models |
methods-heavy journals | strong discoverability for technical papers | whether the database or biological-value component is strong enough |
This is the useful submission implication. Indexing is not the limiting factor for NAR. Resource value, methods usefulness, and editorial identity are the limiting factors.
How to verify the indexing record yourself
If you want to check this directly, the process is short:
- open the NLM Catalog record
- confirm the PubMed and MEDLINE coverage lines
- confirm the PMC line
- confirm Current Indexing Status
- run a direct PubMed journal search for recent articles
- compare those results with the official journal site
That manual check is useful because it confirms both the abstract-level discoverability and the full-text route that make NAR especially reusable.
What we see in PubMed-Indexing Questions for Nucleic Acids Research
For PubMed-indexing questions for Nucleic Acids Research, three patterns come up repeatedly.
The methods-paper visibility worry. Authors sometimes assume a resource or database paper may be harder to find than a traditional disease paper. For NAR, that is usually the wrong concern. The PubMed plus PMC combination is already strong.
The indexing-equals-fit shortcut. We also see authors treat active MEDLINE indexing as if it validates the submission choice. It does not. A visible paper can still be a weak NAR fit if the resource is too small, the method is too narrow, or the utility is underdemonstrated.
The full-text blind spot. Another common miss is underestimating how much full-text access matters for methods and database papers. For NAR, the PMC signal is not trivia. It reinforces the paper’s long-term reuse value.
What indexing does and does not tell you
This page answers the discoverability question. It does not answer whether the manuscript belongs in Nucleic Acids Research.
Indexing tells you:
- the published paper will be visible in biomedical search
- the title is actively indexed for MEDLINE
- the journal also has a PMC route for full-text discoverability
Indexing does not tell you:
- whether the resource or method is broadly useful enough
- whether the database or assay has enough staying power
- whether a different molecular-biology or bioinformatics venue is a better strategic fit
That is why the better next reads are:
If the fit question is what you actually need answered, a Nucleic Acids Research submission readiness check gives you a manuscript-specific signal before you submit.
What the NLM record means in practice for authors
The useful part of the NAR record is not merely that the journal appears in PubMed. It is that the discoverability story combines abstract-level visibility with a PMC full-text route, which matters for the way NAR articles are actually used.
The title begins in 1974, and the searchable PubMed and MEDLINE coverage begins there as well. That means the core indexing story is clean from launch. The PMC line adds a second kind of practical value: readers can often move directly from discovery to full-text reuse.
That matters because NAR papers are often reference infrastructure. A database description, assay protocol, or resource update may be cited and reopened repeatedly over time. PubMed makes the paper easy to find. PMC helps make it easy to use.
Submit If / Think Twice If
Use this indexing answer as enough reassurance if:
- your main concern is whether a published paper will be visible and reusable through standard biomedical search workflows
- you want confirmation that the title remains actively indexed for MEDLINE
- you want to verify that PMC support is also present
Think twice if:
- you are using database coverage as a shortcut for NAR-level fit
- the resource or method may still be too narrow or too lightly validated
- what you actually need is a usefulness-and-identity judgment rather than a database-status answer
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
Practical verdict
Yes, Nucleic Acids Research is indexed in PubMed and currently indexed for MEDLINE, with searchable coverage from volume 1, issue 1 in January 1974 and PMC support also listed.
If your question is whether a published paper will be visible in the biomedical search workflow, the answer is clearly yes. If your real question is whether the manuscript has the right editorial identity for NAR rather than a different molecular-biology or bioinformatics venue, that is a separate fit call. A Nucleic Acids Research submission readiness check is the best next step if you want that answer before submission.
Frequently asked questions
Yes. Nucleic Acids Research is indexed in PubMed and currently indexed for MEDLINE according to the NLM Catalog.
Yes. The NLM Catalog record also lists PMC, which supports full-text discoverability.
The NLM Catalog shows PubMed and MEDLINE coverage from volume 1, issue 1 in January 1974.
Open the journal’s NLM Catalog record, confirm the PubMed, MEDLINE, and PMC lines plus current indexing status, then run a direct PubMed journal search for recent articles.
Sources
- 1. Nucleic Acids Research NLM Catalog record, NLM.
- 2. NLM Catalog help: current indexing status, NLM.
- 3. Nucleic Acids Research journal page, Oxford Academic.
- 4. Nucleic Acids Research author guidelines, Oxford Academic.
- 5. Nucleic Acids Research in PubMed, PubMed.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
- Nucleic Acids Research submission guide
- How to Avoid Desk Rejection at Nucleic Acids Research (2026)
- Is Nucleic Acids Research a Good Journal? Fit Verdict
- Nucleic Acids Research Response to Reviewers: How to Write a Rebuttal That Clears Re-Review (2026)
- Is Your Paper Ready for Nucleic Acids Research? A Guide to NAR's Three Editorial Tracks
- Nucleic Acids Research 'Under Review': What the Status Means
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.